Jefferies analyst, Brian Abrahams, reiterated his Buy rating on shares of Gilead Sciences (NASDAQ: GILD) after attending the company's analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE